Deposition of discrete nanoparticles on a nanostructured surface of an implant
US-9204944-B2 · Dec 8, 2015 · US
US9943624B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9943624-B2 |
| Application number | US-201314646723-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 24, 2013 |
| Priority date | Nov 30, 2012 |
| Publication date | Apr 17, 2018 |
| Grant date | Apr 17, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides novel surface coatings having surface polymer brushes with zwitterionic and antibiotics-conjugated side chains and synergistic anti-fouling and bactericidal properties. The surface coatings may be prepared using highly efficient surface-initiated “living” polymerization. The design of the surface polymer brushes are highly modular, allowing independent tuning of the anti-fouling and bactericidal properties, e.g., by varying the chemical nature of the zwitterionic motif and the antibiotic agent, the chemistry through which the antibiotic agent is conjugated to the polymer side chains, the molecular weight of the polymer brushes (e.g., thickness of coating and density of respective functional motifs), and the spatial arrangement of the respective functional motifs (e.g., homopolymers, block copolymers, random copolymers) to achieve optimal and sustained anti-infection outcome for a given application.
Opening claim text (preview).
The invention claimed is: 1. A co-polymer comprising repeating units having structures of: wherein R 1 , R 3 each is independently a hydrogen, alkyl, alkyloxy; R 2 , R 4 each is independently a hydrogen, (C 1 -C 15 ) alkyl, (C 1 -C 15 ) alkyloxy; L z is a linking group; L ab is a linking group; R z is a pendant group comprising a zwitterionic group; and R ab is a pendant group comprising an antibacterial moiety, wherein the antibacterial moiety is vancomycin or a derivative thereof. 2. The co-polymer of claim 1 , wherein the co-polymer comprises the structure: wherein each of m, n, p, and q is an integer selected from about 0 to about 500. 3. The co-polymer of claim 1 , wherein the zwitterionic group is selected from phosphorylcholine, sulfobetaine, and carboxybetaine. 4. The co-polymer of claim 2 , comprising repeating units of structures: wherein L z is a linking group; and L ab is a linking group. 5. The co-polymer of claim 4 , wherein the co-polymer comprises the structure: wherein each of m, n, p, and q is an integer selected from about 0 to about 500. 6. The co-polymer of claim 5 , wherein each of R 1 , R 3 , R 2 , and R 4 is hydrogen. 7. The co-polymer of claim 5 , wherein at least one of R 1 , R 3 , R 2 , and R 4 is not hydrogen. 8. The co-polymer of claim 6 , wherein each of L z and L ab is independently—(CH 2 ) i —, wherein i is an integer from about 1 to about 20.
and containing nitrogen and oxygen · CPC title
using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent · CPC title
Homopolymers or copolymers of acrylic acid esters · CPC title
Metals or alloys · CPC title
Biocides, antimicrobial agents, antiseptic agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.